Zipalertinib in Patients With Epidermal Growth Factor Receptor Exon 20 Insertion-Positive Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy With or Without Amivantamab.

Journal:

Journal of Clinical Oncology

Published:

2025-06-02

DOI:

10.1200/jco-25-00763

Affiliations:

23

Authors:

60

Go to article

Institutions	Authors	Share
Cullinan Therapeutics, Inc., United States of America (USA)	5.000000	0.20
National Cancer Centre Singapore (NCCS), Singapore	1.000000	0.04
Clínica Universidad de Navarra (CUN), UNAV, Spain	1.000000	0.04
Massachusetts General Hospital (MGH), United States of America (USA)	1.000000	0.04
Hospital Universitario Puerta de Hierro Majadahonda, UAM, Spain	1.000000	0.04
Seoul National University Bundang Hospital (SNUBH), South Korea	1.000000	0.04
Asan Medical Center (AMC), South Korea	1.000000	0.04
La Fe University Hospital, Spain	1.000000	0.04
National Cancer Center Hospital East, Japan	1.000000	0.04
Virginia Cancer Specialists (VCS), United States of America (USA)	1.000000	0.04
NUS National University Hospital (NUH), Singapore	1.000000	0.04
City of Hope, United States of America (USA)	1.000000	0.04
The University of Hong Kong (HKU), China	1.000000	0.04
National Taiwan University Hospital (NTUH), Taiwan	1.000000	0.04
IRCCS European Institute of Oncology (IEO), Italy	1.000000	0.04
NYU Laura and Isaac Perlmutter Cancer Center, United States of America (USA)	1.000000	0.04
Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital (NKI-AVL), Netherlands	1.000000	0.04
Samsung Medical Center (SMC), South Korea	1.000000	0.04
Osaka City General Hospital (OCGH), Japan	1.000000	0.04
Hollings Cancer Center, MUSC, United States of America (USA)	1.000000	0.04
Memorial Sloan Kettering Cancer Center (MSKCC), United States of America (USA)	0.500000	0.02
Weill Cornell Medicine, United States of America (USA)	0.500000	0.02

Interested in Oncology and Carcinogenesis?